Printer Friendly

Browse Sorafenib topic

Articles

1-221 out of 221 article(s)
Title Author Type Date Words
Aveo says Phase 3 TIVO-3 results published in European Urology. Sep 15, 2020 187
Tiziana Life Sciences Gets US Patent For Milciclib In Cancer. Aug 21, 2020 340
Curmudgeon's Corner: New Way to Target Cancer Stem Cells: Doxycycline, Vitamin C, and Berberine. Schor, Jacob Aug 1, 2020 2228
Q Biomed to scale-up production of potential liver cancer chemotherapeutic Uttroside-B as it gears up for IND filing. Jul 23, 2020 498
Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Ahn, Seon Young; Kim, Suk Bae; Han Song, Il Jun 30, 2020 5811
Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity. Jia, Wentao; Wang, Lina Jun 30, 2020 11398
Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC. Hajighasemlou, Saieh; Nikbakht, Mohsen; Pakzad, Saeedreza; Muhammadnejad, Samad; Gharibzadeh, Safoor Jun 30, 2020 4753
Inhibition of the CDK4/6-Cyclin D-Rb Pathway by Ribociclib Augments Chemotherapy and Immunotherapy in Renal Cell Carcinoma. Chen, Dehong; Sun, Xiaosong; Zhang, Xuejun; Cao, Jun Jun 30, 2020 5296
Zinc Oxide Nanoparticle Synergizes Sorafenib Anticancer Efficacy with Minimizing Its Cytotoxicity. Nabil, Ahmed; Elshemy, Mohamed M.; Asem, Medhat; Abdel-Motaal, Marwa; Gomaa, Heba F.; Zahran, Faten; Jun 30, 2020 8021
Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines? Mohammed, Baba Sulemana; Aidoo, Matthew Clinical report Jun 30, 2020 5324
Tiziana Life Sciences outlines a busy schedule for 2020. Jun 19, 2020 501
Tiziana Life Sciences outlines a busy schedule for 2020. Jun 19, 2020 499
Roche's Tecentriq Approved In US For Most Common Form Of Liver Cancer. Jun 2, 2020 346
LONDON BRIEFING: Tesco's Finance Boss Alan Stewart To Retire. Jun 2, 2020 1674
GLOBAL TOP NEWS SUMMARY: European Stocks Shrug Off US Unrest. Jun 2, 2020 1824
Clinicopathologic Results of the Surgical Management of Thyroid Gland Pathologies. Yumusakhuylu, Ali Cemal; Asya, Orhan; Gundogdu, Yavuz; Oysu, Cagatay Jun 1, 2020 4275
Aveo Oncology announces FDA acceptance for NDA filing for tivozanib. Jun 1, 2020 193
Elucidation of the Molecular Mechanisms Underlying Sorafenib Induced Hepatotoxicity. AlAsmari, Abdullah F.; Ali, Nemat; AlAsmari, Fawaz; AlAnazi, Wael A.; Alqahtani, Faleh; Alharbi, Met May 31, 2020 5571
Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy. Ye, Haiwei; Zhou, Liping; Jin, Haili; Chen, Yunhua; Cheng, Die; Jiang, Ying May 31, 2020 5581
LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma. Tang, Xiaofeng; Zhang, Weichen; Ye, Yufu; Li, Hong; Cheng, Longyu; Zhang, Min; Zheng, Shusen; Yu, Ju May 31, 2020 3767
Splenectomy for Solitary Splenic Metastasis in Recurrent Papillary Thyroid Cancer. A Case Report and Literature Review. Maffuz-Aziz, Antonio; Garnica, Gabriel; Lopez-Hernandez, Silvia; Pineda-Diaz, Janet; Baquera-Heredia May 31, 2020 2484
Aveo presents results from final analysis of Phase 3 TIVO-3 trial. May 29, 2020 291
FDA approves Genentech's Tecentriq in combination with Avastin. May 29, 2020 222
Comparison of Inflammatory Indexes in Patients Treated with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Observational Study. Cinkir, Havva Yesil; Dogan, Ilkay Report May 21, 2020 3824
Tiziana's Milciclib drug meets primary endpoint in Phase 2a trial in Hepatocellular Carcinoma. May 15, 2020 187
Tiziana Life delighted with data from liver cancer treatment trials in Italy. May 15, 2020 356
Tiziana's Milciclib drug meets primary endpoint in Phase 2a trial in Hepatocellular Carcinoma. May 15, 2020 185
Tiziana Life delighted with data from liver cancer treatment trials in Italy. May 15, 2020 354
Tiziana Life Sciences has four submissions accepted to virtual ASCO event. May 12, 2020 443
Tiziana Life Sciences has four submissions accepted to virtual ASCO event. May 12, 2020 441
Treatment strategies and prognosis for initially unresectable ruptured hepatocellular carcinoma: a single-center experience in 94 patients. Zhou, Chun; Zu, Qing-Quan; Liu, Xing-Long; Wang, Bin; Zhou, Chun-Gao; Shi, Hai-Bin; Liu, Sheng May 1, 2020 5795
IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer. Zhang, Lei; Liu, Wen; Liu, Fangyan; Wang, Qun; Song, Mengjiao; Yu, Qi; Tang, Kun; Teng, Tieshan; Wu, Apr 30, 2020 6812
Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD. Sobash, Philip T.; Guddati, Achuta K.; Kota, Vamsi Apr 30, 2020 1943
Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study. Li, Chaofeng; Tang, Tao; Wang, Wenyue Clinical report Apr 30, 2020 4156
Clinical and Histopathological Profile of Subcorneal Pustular Dermatosis. Narayanan, Soumya Venkitaramanan; Anitha, K. Apr 13, 2020 2646
Aveo submits NDA to FDA for tivozanib. Mar 31, 2020 266
Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment. Liu, Yao; Xue, Dongying; Zhang, Xiaogang; Gao, Fangyuan; Sun, Le; Yang, Xue; Li, Yuxin; Zhang, Qun; Mar 31, 2020 5194
Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit. Protopapa, Maria-Nikoletta; Lagadinou, Maria; Papagiannis, Theodoros; Gogos, Charalambos A.; Solomou Mar 31, 2020 1357
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target. Baboci, Lorena; Capolla, Sara; Di Cintio, Federica; Colombo, Federico; Mauro, Prisca; Bo, Michele Da Mar 31, 2020 11821
Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma. Yang, Yang; Chen, Qin; Yu, Wen-Ying; Zhang, Huan-Huan; Zhong, Yu-Sen; Zhang, Song-Zhao; Wang, Jia-Fe Mar 1, 2020 7996
Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib. Nunes, Goncalo; Fonseca, Cristina; Patita, Marta; Aleixo, Maria Joao; Ramalho, Miguel; Fonseca, Jorg Letter to the editor Feb 1, 2020 1400
Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib. Nunes, Goncalo; Fonseca, Cristina; Patita, Marta; Aleixo, Maria Joao; Ramalho, Miguel; Fonseca, Jorg Feb 1, 2020 1491
Exelixis Partner Takeda Files New Drug Application in Japan for Cabometyx for Advanced Hepatocellular Carcinoma. Jan 30, 2020 501
AstraZeneca announces grant of Orphan Drug Designation in the US to Imfinzi and tremelimumab for liver cancer treatment. Jan 21, 2020 420
AstraZeneca announces grant of Orphan Drug Designation in the US to Imfinzi and tremelimumab for liver cancer treatment. Jan 21, 2020 416
Imfinzi and tremelimumab granted Orphan Drug Designation in the US for liver cancer. Jan 20, 2020 1635
OncoMyx Therapeutics Forms Scientific Advisory Board. Jan 14, 2020 644
Study of the Binding Interaction between Wortmannin and Calf Thymus DNA: Multispectroscopic and Molecular Docking Studies. Mehran, Shiva; Rasmi, Yousef; Karamdel, Hamid Reza; Hossinzadeh, Ramin; Gholinejad, Zafar Jan 1, 2020 4016
WNT7A Overexpression Inhibits Growth and Migration of Hepatocellular Carcinoma via the [beta]-Catenin Independent Pathway. Lan, Lihui; Wang, Wei; Huang, Yue; Zhao, Chenghai; Bu, Xianmin Dec 31, 2019 4482
Cryoablation of a Symptomatic Chest Wall Desmoid Tumor Underneath a Silicone Breast Implant. Kulkarni, Siddhant S.; Deipolyi, Amy R.; Bryce, Yolanda C.D.; Erinjeri, Joseph P. Dec 31, 2019 1214
MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway. Xia, Qing; Han, Tao; Yang, Pinghua; Wang, Ruoyu; Li, Hengyu; Zhang, Jin; Zhou, Xinfeng Dec 31, 2019 6611
Tivozanib Bests Sorafenib in Metastatic Renal Cell Carcinoma; Progression-free survival longer in those receiving tivozanib as third- or fourth-line therapy. Dec 23, 2019 272
Aplastic Anemia and Good Syndrome in a Heavily Treated Stage IV Thymoma Patient: A Case Report and Review of the Literature. Ranieri, Sofia Chiatamone; Trasarti, Stefania; Arleo, Maria Antonietta; Bizzoni, Luisa; Bonanni, Liv Nov 30, 2019 3489
Preoperative Serum IL6, IL8, and TNF-[alpha] May Predict the Recurrence of Hepatocellular Cancer. Cai, Huayong; Zhang, Yu; Meng, Fanyu; Cui, Chao; Li, Hao; Sui, Minghao; Zhang, Haoyun; Lu, Shichun Nov 30, 2019 5432
Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma. Zhang, Jie; Song, Qianqian; Liu, Jinxia; Lu, Lina; Xu, Yuqing; Zheng, Wenjie Nov 30, 2019 6126
Emerging Role of Ferroptosis in Acute Kidney Injury. Hu, Zhaoxin; Zhang, Hao; Yang, Shi-Kun; Wu, Xueqin; He, Dong; Cao, Ke; Zhang, Wei Nov 30, 2019 5830
Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions. Teng, Linxin; Wang, Kaiyuan; Liu, Yu; Ma, Yanxia; Chen, Weiping; Bi, Lei Nov 30, 2019 7311
Insulin-Like Growth Factor Binding Protein 5--A Probable Target of Kidney Renal Papillary Renal Cell Carcinoma. Wang, Shuqiang; Hong, Quan; Geng, Xiaodong; Chi, Kun; Cai, Guangyan; Wu, Di Nov 30, 2019 5394
Roche reports positive results from phase three Tecentriq trial in combination with Avastin. Nov 26, 2019 162
Roche reports positive results from phase three Tecentriq trial in combination with Avastin. Nov 26, 2019 158
Aveo Presents Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma. Nov 19, 2019 1009
US FDA Accepts for Priority Review Bristol-Myers Squibb's Application for Opdivo Plus Yervoy Combination for Patients with Previously Treated Advanced Hepatocellular Carcinoma. Nov 13, 2019 622
Bristol-Myers Squibb UK (NYSE:BMY) - U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb's Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combination for Patients with Previously Treated Advanced Hepatocellular Carcinoma -- 11/11/2019. Nov 12, 2019 265
Aveo Oncology Provides Regulatory Update for Tivozanib in Renal Cell Carcinoma. Nov 5, 2019 814
Aveo Pharmaceuticals provides update after FDA meeting discussing TIVO-3 results. Nov 4, 2019 533
Fly Intel: Pre-market Movers. Nov 4, 2019 220
HEPATOCELLULAR CARCINOMA AT INITIAL PRESENTATION AND ITS SUBSEQUENT THERAPEUTIC OPTIONS OFFERED: A TERTIARY CARE HOSPITAL EXPERIENCE. Asim Shehzad, Rabia Sajjad, Khawar Shabbir, Zafar Ali Qureshi, Farrukh Saeed and Abdullah Qamar Oct 31, 2019 2027
The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells. Yang, Yue; He, Pingya; Li, Ning Oct 31, 2019 5640
Eli Lilly and Company UK. Oct 29, 2019 3528
Chugai Pharmaceutical Co., Ltd. - Tecentriq in Combination with Avastin Increases Overall Survival and Progression-free Survival as an Initial Treatment in People with Unresectable Hepatocellular Carcinoma -- 21/10/2019. Oct 22, 2019 241
Eli Lilly & Company (NYSE: LLY). Oct 21, 2019 3791
Roche's Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma. Oct 21, 2019 1465
Roche's Tecentriq In Combination With Avastin Improves Survival. Oct 21, 2019 199
Genentech says Phase III IMbrave150 study met co-primary endpoints. Oct 21, 2019 226
Eli Lilly and Company UK. Oct 15, 2019 3523
Eli Lilly and Company UK. Oct 8, 2019 3528
Eli Lilly & Company (NYSE: LLY). Oct 7, 2019 3493
Eli Lilly and Company UK. Oct 2, 2019 3523
Eli Lilly & Company (NYSE: LLY). Oct 1, 2019 3488
Q BioMed, Chemveda. Oct 1, 2019 346
Neutrophil-to-lymphocyte ratio alone may not be a true indicator of the severity of acute pancreatitis. Tanoglu, Alpaslan; Duzenli, Tolga Letter to the editor Oct 1, 2019 626
Neutrophil-to-lymphocyte ratio alone may not be a true indicator of the severity of acute pancreatitis. Tanoglu, Alpaslan; Duzenli, Tolga Letter to the editor Oct 1, 2019 623
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels. Villalpando-Rodriguez, Gloria E.; Blankstein, Anna R.; Konzelman, Carmen; Gibson, Spencer B. Sep 30, 2019 7616
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. Ludwig, Andrew D.; Labadie, Kevin P.; Seo, Y. David; Hamlin, Donald K.; Nguyen, Holly M.; Mahadev, V Sep 30, 2019 4595
Tiziana Loss Narrows In "Busy" First Half, Looks To Advance Drug Tests. Sep 30, 2019 166
Roche's Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma. Sep 27, 2019 1919
Eli Lilly and Company UK. Sep 24, 2019 3528
Eli Lilly & Company (NYSE: LLY). Sep 23, 2019 3488
In vivo induction of hepatocellular carcinoma by diethylnitrosoamine and pharmacological intervention in Balb C mice using Bergenia ciliata extracts/Inducao in vivo de carcinoma hepatocelular por dietilnitrosoamina e intervencao farmacologica em camundongos balb c usando extratos de Bergenia ciliata. Dar, K.K.; Ali, S.; Ejaz, M.; Nasreen, S.; Ashraf, N.; Gillani, S.F.; Shafi, N.; Safeer, S.; Khan, M Sep 12, 2019 7035
Q BioMed, Chemveda enter agreement for synthesis of chemotherapeutic. Sep 11, 2019 294
Eli Lilly & Company (NYSE: LLY). Sep 11, 2019 3493
Aveo Pharma announces results from TIVO-3 trial. Sep 10, 2019 157
Eli Lilly & Company (NYSE: LLY). Sep 3, 2019 3493
Primary Cardiac Epithelioid Angiosarcoma in a Latin American Patient: Case Report and Literature Review. Morgenstern-Kaplan, Dan; Aboitiz-Rivera, Carlos Manuel; Blachman-Braun, Ruben; Vazquez-Manriquez, Ma Aug 31, 2019 2219
Acute Deterioration of Pulmonary Arterial Hypertension (PAH) in a Patient with Neurofibromatosis Type 1 (NF1). Tanaka, Seiya; Kawahara, Fuko; Miyamoto, Taro; Tsurusaki, Satoshi; Sanuki, Yoshihito; Ozumi, Kiyoshi Aug 31, 2019 1825
Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment. Bernascon, Paolo; Borsani, Oscar Aug 31, 2019 9846
Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study. Yuan, Jia; Yin, Xin; Tang, Bei; Ma, Hui; Zhang, Lan; Li, Lixin; Chen, Rongxin; Xie, Xiaoying; Ren, Z Report Aug 31, 2019 3395
Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1. Chen, Yan; Zhang, Jiongshan; Liu, Mengting; Zou, Zengcheng; Wang, Fenglin; Hu, Hao; Sun, Baoguo; Zha Aug 31, 2019 5899
Eli Lilly & Company (NYSE: LLY). Aug 27, 2019 3493
Eli Lilly & Company (NYSE: LLY). Aug 20, 2019 3493
Eli Lilly & Company (NYSE: LLY). Aug 13, 2019 3493
Transgene Provides an Update After the Interim Futility Analysis of the PHOCUS Study of Pexa-Vec in Liver Cancer. Aug 9, 2019 664
Eli Lilly & Company (NYSE: LLY). Aug 6, 2019 3493
Transgene reports developments in Pexa-Vec Liver Cancer study. Aug 6, 2019 188
Transgene reports developments in Pexa-Vec Liver Cancer study. Aug 6, 2019 184
Transgene Provides Update on PHOCUS Study of Pexa-Vec in Liver Cancer Following Planned Interim Futility Analysis. Aug 5, 2019 603
Jiedu Granule Combined with Transcatheter Arterial Chemoembolization and Gamma Knife Radiosurgery in Treating Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Wang, Jianchu; Luo, Jinhong; Yin, Xiaolan; Huang, Wei; Cao, Huangming; Wang, Guilin; Wang, Jincheng; Jul 31, 2019 5095
Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma. Zhou, Yun; Li, Ke; Li, Fan; Han, Shuang; Wang, Yang; Li, Xueping; Zhan, Yonghua Jul 31, 2019 8526
Medullary Thyroid Carcinoma: An Update on Imaging. Kushchayev, Sergiy V.; Kushchayeva, Yevgeniya S.; Tella, Sri Harsha; Glushko, Tetiana; Pacak, Karel; Jul 31, 2019 10426
Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy. Takahashi, Hiroaki; Mori, Kensaku; Sekino, Yuta; Okumura, Toshiyuki; Hiyama, Takashi; Fukuda, Kuniak Jul 31, 2019 4073
Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial. Zhang, Jing-Hao; Zheng, Chao; Zhu, Xiao-Jun; Zhang, Xin; Hou, Zhi-Jun; Zhou, Zhen-Hua; Wang, Yu-Qing Jul 31, 2019 3749
Biotransformation of Cranberry Proanthocyanidins to Probiotic Metabolites by Lactobacillus rhamnosus Enhances Their Anticancer Activity in HepG2 Cells In Vitro. Rupasinghe, H.P. Vasantha; Parmar, Indu; Neir, Sandhya V. Jul 31, 2019 9371
Merck & Co (NYSE:MRK). Jul 29, 2019 3388
Merck & Co (NYSE: MRK). Jul 22, 2019 3392
Merck & Co (NYSE: MRK). Jul 16, 2019 3392
Deciphera Pharmaceuticals Names Susan L. Kelley, M.D., to its Board of Directors. Jul 11, 2019 342
Merck & Co (NYSE: MRK). Jul 8, 2019 3394
Treatment Outcomes in Anaplastic Thyroid Cancer. Corrigan, Kelsey L.; Williamson, Hannah; Range, Danielle Elliott; Niedzwiecki, Donna; Brizel, David Jun 30, 2019 6299
Asparagus Polysaccharide Suppresses the Migration, Invasion, and Angiogenesis of Hepatocellular Carcinoma Cells Partly by Targeting the HIF-1[alpha]/VEGF Signalling Pathway In Vitro. Cheng, Wei; Cheng, Ziwei; Xing, Dongwei; Zhang, Minguang Jun 30, 2019 5581
Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis. Zhou, Rui-sheng; Wang, Xiong-Wen; Sun, Qin-feng; Ye, Zeng Jie; Liu, Jian-wei; Zhou, Dai-Han; Tang, Y Jun 30, 2019 6611
Merck & Co (NYSE: MRK). Jun 24, 2019 3395
Iran Unveils 7 New Knowledge-Based Products. Jun 19, 2019 467
Merck & Co (NYSE: MRK). Jun 18, 2019 3384
Iran Unveils 9 New Home-Made Hi-Tech Drugs. Jun 18, 2019 405
Merck & Co (NYSE: MRK). Jun 13, 2019 3386
Iran Boasts 3.3% Rise in Medicine Production. Jun 6, 2019 518
Bristol-Myers Squibb (NYSE:BMY) - Bristol-Myers Squibb Announces First Presentation of Results for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combination in Advanced Hepatocellular Carcinoma at ASCO 2019 -- 3/6/2019. Financial report Jun 4, 2019 507
Merck & Co (NYSE:MRK). Jun 4, 2019 3397
Bristol-Myers' Opdivo+Yervoy HCC study yields 31% ORR. Jun 3, 2019 131
How patent law reform can improve affordability and accessibility of medicines in South Africa: Four medicine case studies. Tomlinson, C.; Waterhouse, C.; Hu, Y.Q.; Meyer, S.; Moyo, H. Report Jun 1, 2019 4810
In vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus igneus against Hepatocellular Carcinoma (HepG2) Cells. Josephine, I. Glory; Punnagai, K. Jun 1, 2019 2458
Radyoembolizasyon: Anjiyografik Teknik, Zor Olgular/Radioembolization: Angiographic Techniques, Difficult Cases. Poyanli, Arzu Jun 1, 2019 1701
Radyoembolizasyon Tedavisinde Yanit Degerlendirme: Tuzaklar ve Standardizasyon/Assessment of Radioembolization Treatment Response: Standardization, Tips & Tricks. Yakupoglu, Abdullah Jun 1, 2019 2834
HCC Tedavisinde Radyoembolizasyon/Radioembolization in the Treatment of HCC. Cantasdemir, Murat Jun 1, 2019 3998
Combination treatment of usnic acid and sorafenib on hepatocellular carcinoma. Yurdacan, Beste; Egeli, Unal; Eskiler, Gamze Guney; Eryilmaz, Isil Ezgi; Cecener, Gulsah; Tunca, Ber Disease/Disorder overview Jun 1, 2019 329
Merck & Co (NYSE: MRK). May 29, 2019 3397
Iranian VP Underlines Extensive Plans to Confront US Sanctions. May 26, 2019 244
Eli Lilly & Company (NYSE: LLY) - Lilly's CYRAMZA[R] (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma -- 15/5/2019. May 20, 2019 711
Merck & Co (NYSE:MRK). May 20, 2019 3389
USFDA approves Eli Lilly's CYRAMZA. May 15, 2019 194
USFDA approves Eli Lilly's CYRAMZA. May 15, 2019 190
Merck & Co (NYSE:MRK). May 14, 2019 3392
Eli Lilly announces FDA approval for Cyramza for patients with HCC. May 13, 2019 142
Iran Industrializes Home-Made Drug to Treat Liver Cancer. May 12, 2019 390
Iran Unveils 4 New Drugs for Treating Cancer, Diabetes. May 7, 2019 551
Iran Vows to Indigenize Sanctioned Medicine. May 7, 2019 661
Iran Develops Know-How for Production of 4 Vital Cancer, Diabetes Drugs. May 6, 2019 427
Merck & Co (NYSE:MRK). May 6, 2019 3394
Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature. Chohan, Moaz B.Y.; Taylor, Nick; Coffin, Carla; Burak, Kelly W.; Bathe, Oliver F. Apr 30, 2019 3703
CDK5RAP3 Participates in Autophagy Regulation and Is Downregulated in Renal Cancer. Li, Jun; Hu, Xinyi; Su, Ming; Shen, Hongliang; Qiu, Wei; Tian, Ye Apr 30, 2019 3686
Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment. Wu, Rong; Li, Xiao-Yan; Wang, Wen-Hai; Cai, Fei-Fei; Chen, Xiao-Le; Yang, Meng-Die; Pan, Qiu-Sha; Ch Apr 30, 2019 7080
Merck & Co (NYSE:MRK). Apr 29, 2019 3395
Tiziana Reports Encouraging Interim Clinical Data from an Ongoing Phase 2a Clinical Trial with Milciclib in Patients with Advanced Liver Cancer. Apr 29, 2019 754
Merck & Co (NYSE: MRK). Apr 23, 2019 3385
Merck & Co (NYSE:MRK). Apr 15, 2019 3393
MiNA Therapeutics Presents Pre-Clinical Data Supporting Combination of MTL-CEBPA with Sorafenib and Other Cancer Treatments at AACR. Apr 3, 2019 446
Follikuler Tiroit Karsinomunun Skalp ve Ust Ekstremitede Kitlesel Cilt Metastazlari/Multiple Cutaneous Metastasis of Follicular Thyroid Carcinoma in the Scalp and Upper Extremities. Yildirim, Sibel; Buyukatalay, Zahide Ciler; Dursun, Gursel Report Apr 1, 2019 1661
Aptose Biosciences presents preclinical data on CG-806, APTO-253 at AACR. Apr 1, 2019 283
Remodelling and Improvements in Organoid Technology to Study Liver Carcinogenesis in a Dish. Tharehalli, Umesh; Svinarenko, Michael; Lechel, Andre Mar 31, 2019 5652
Hepatocellular Carcinoma: From Molecular Basis to Novel Treatment Approaches. Akkiz, Hikmet Mar 31, 2019 757
Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid. Jakobsson, Ulrika; Makila, Ermei; Airaksinen, Anu J.; Alanen, Osku; Etile, Asenath; Koster,Ulli; Ran Mar 31, 2019 6457
Merck (MRK). Mar 20, 2019 2707
Innovent doses first patient under the ORIENT-32 trial to evaluate the Tyvyt & IBI305 combination in patients with advanced HCC. Feb 28, 2019 289
Innovent doses first patient under the ORIENT-32 trial to evaluate the Tyvyt & IBI305 combination in patients with advanced HCC. Feb 28, 2019 285
Merck says 'disappointed' KEYNOTE-240 did not meet co-primary endpoints. Feb 19, 2019 277
Hepatocellular Carcinoma-Associated Polymyositis Presenting With Unilateral Upper Limb Subcutaneous Edema. Meng-Ko, Tsai; Yi-Hsin, Chen; You-Hsin, Chiu; Kuo-Lung, Lai Dec 1, 2018 2763
Sorafenib Reveals Anti-Arthritic Potentials in Collagen Induced Experimental Arthritis Model. Gozel, Nevzat; Cakirer, Masallah; Karatas, Ahmet; Tuzcu, Mehmet; Ozdemir, Fethi Ahmet; Dagli, Adile Sep 1, 2018 3248
Ipsen - Ipsen announces CELESTIAL phase 3 pivotal trial results in the New England Journal of Medicine - 4/7/2018. Jul 19, 2018 708
Cabozantinib Improves Survival in Advanced Hepatocellular Cancer; Significantly longer overall and progression-free survival with cabozantinib than placebo. Jul 6, 2018 265
Globally, Liver Cancer Is Fourth Leading Cause of Cancer Death: But many cases can be prevented through vaccination, antiviral treatment, and other interventions, experts say. Mar 1, 2018 437
Synthesis of Folic Acid-Modified DOX@ZIF-8 Nanoparticles for Targeted Therapy of Liver Cancer. Bi, Jian; Lu, Yishan; Dong, Yan; Gao, Ping Jan 1, 2018 2724
Heparin-Based Nanoparticles: An Overview of Their Applications. Rodriguez-Torres, Maria del Pilar; Acosta-Torres, Laura Susana; Diaz-Torres, Luis Armando Jan 1, 2018 6683
Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma. Degroote, H.; Van Dierendonck, A.; Geerts, A.; Van Vlierberghe, H.; Devisscher, L. Jan 1, 2018 6195
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations. Xie, Yingjun; Xiang, Yien; Sheng, Jiyao; Zhang, Dan; Yao, Xiaoxiao; Yang, Yongsheng; Zhang, Xuewen Jan 1, 2018 6548
Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis. Lin, Wan-fu; Zhong, Mao-feng; Zhang, Yu-ren; Wang, Huan; Zhao, He-tong; Cheng, Bin-bin; Ling, Chang- Jan 1, 2018 5838
Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. Kumar, Nithu M; Sreelatha, Priyanka; Sadasivan, Shine; Jain, Ankur; Anila, K N Case study Jan 1, 2018 1258
Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients. Topkan, Erkan; Selek, Ugur; Ozdemir, Yurday; Besen, Ali A.; Guler, Ozan C.; Yildirim, Berna A.; Mert Jan 1, 2018 5650
Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-[beta] and ERK 1/2 Pathways. Lestari, Novriantika; Louisa, Melva; Soetikno, Vivian; Suwana, Averina Geffanie; Ramadhan, Putra And Jan 1, 2018 5146
Macroscopic Portal Vein Thrombosis in HCC Patients. Akkiz, Hikmet; Carr, Brian I.; Kuran, Sedef; Karaogullarindan, Umit; Uskudar, Oguz; Tokmak, Salih; A Jan 1, 2018 5291
Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma. Odabas, Gorkem; Cetin, Metin; Turhal, Serdar; Baloglu, Huseyin; Sayan, A. Emre; Yagci, Tamer Jan 1, 2018 5289
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma. Korhan, Peyda; Yilmaz, Yeliz; Bagirsakci, Ezgi; Gunec, Aycim; Topel, Hande; Carres, Brian I.; Atabey Jan 1, 2018 5723
Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two Cases. Yamazaki, Haruhiko; Kishida, Takeshi; Noguchi, Go; Iwasaki, Hiroyuki; Suganuma, Nobuyasu; Masudo, Ka Jan 1, 2018 2460
Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy. Suarez, Oscar; Perez, Maria; Garzon, Martin; Daza, Rodrigo; Hernandez, Geovanny; Salinas, Carolina; Jan 1, 2018 3648
Bacillus cereus Typhlitis in a Patient with Acute Myelogenous Leukemia: A Case Report and Review of the Literature. Denham, James D.; Nanjappa, Sowmya; Greene, John N. Jan 1, 2018 2099
Metastatic Melanoma of Uncertain Primary with 5-Year Durable Response after Conventional Therapy: A Case Report with Literature Review. Chantharasamee, Jomjit; Treetipsatit, Jitsupa Jan 1, 2018 2712
Metastasis of Hepatocellular Carcinoma to the Esophagus: Case Report and Review. Harada, Jun-ichiro; Matsutani, Takeshi; Hagiwara, Nobutoshi; Kawano, Yoichi; Matsuda, Akihisa; Tania Jan 1, 2018 2606
Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. Chen, Erbao; Xu, Xiaojing; Liu, Ruiqi; Liu, Tianshu Jan 1, 2018 6834
Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies. Bertino, Gaetano; Demma, Shirin; Ardiri, Annalisa; Proiti, Maria; Malaguarnera, Giulia; Bertino, Nic Report Jan 1, 2018 12384
Role of ncRNAs in Hepatocellular Carcinoma. Tu, Kangsheng; Dong, Qiongzhu; Tao, Junyan Jan 1, 2018 728
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma. Sukowati, Caecilia H.C.; Patti, Riccardo; Pascut, Devis; Ladju, Rusdina B.; Tarchi, Paola; Zanotta, Jan 1, 2018 4752
The Diverse Mechanisms of miRNAs and lncRNAs in the Maintenance of Liver Cancer Stem Cells. Zhao, Jing; Fu, Yan; Wu, Jing; Li, Juan; Huang, Guangjian; Qin, Lunxiu Jan 1, 2018 6753
Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization. Yao, Erhua; Chen, Jinghong; Zhao, Xiaofang; Zheng, Yinyan; Wu, Xianheng; Han, Fei; Huang, Hecheng; L Jan 1, 2018 4050
Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition. He, Qiang; Li, Hui; Meng, Fanzhi; Sun, Xiangjun; Feng, Xu; Chen, Jiang; Li, Libo; Liu, Jinghua Jan 1, 2018 7397
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. De Matteis, Serena; Ragusa, Andrea; Marisi, Giorgia; De Domenico, Stefania; Gardini, Andrea Casadei; Jan 1, 2018 10033
Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology. Gong, Benjiao; Kao, Yanlei; Zhang, Chenglin; Sun, Fudong; Zhao, Huishan Jan 1, 2018 4718
The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways. Liang, Shufang; Zou, Yong; Gao, Jingdong; Liu, Xiaolin; Lin, Wanfu; Yin, Zifei; Du, Juan; Zhang, Ya' Jan 1, 2018 3833
Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant. Rahmat, Leena T.; Nguyen, Anna; Abdulhaq, Haifaa; Prakash, Sonam; Logan, Aaron C.; Mannis, Gabriel N Jan 1, 2018 2349
Terapia metrinomica en el manejo del paciente veterinario con cancer. Correal Suarez, Maria Lucia; Bortolotti Viera, Rafaela; Carla Camplesi, Annelise Sep 1, 2017 6928
Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression. Kondo, Masaaki; Numata, Kazushi; Hara, Koji; Nozaki, Akito; Fukuda, Hiroyuki; Chuma, Makoto; Maeda, Report Jan 1, 2017 5663
Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular Carcinoma. Yang, Shuohui; Lin, Jiang; Lu, Fang; Han, Zhihong; Fu, Caixia; Gu, Hongchen Report Jan 1, 2017 7045
Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion. Wu, Candace; Shemisa, Kamal Case study Jan 1, 2017 5012
Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma. Kasahara, Ryo; Nakaigawa, Noboru; Kobayashi, Kazuki Clinical report Jan 1, 2017 1197
Selective and Irreversible Induction of Necroptotic Cell Death in Lung Tumorspheres by Short-Term Exposure to Verapamil in Combination with Sorafenib. Yakisich, Juan Sebastian; Kulkarni, Yogesh; Azad, Neelam; Iyer, Anand Krishnan V. Report Jan 1, 2017 6283
Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study. Kim, Sung Han; Kim, Sohee; Nam, Byung-Ho; Lee, Sang Eun; Kim, Choung-Soo; Seo, Ill Young; Kim, Tae N Report Jan 1, 2017 7912
Ginkgo biloba extract in combination with sorafenib is clinically safe and tolerable in advanced hepatocellular carcinoma patients. Cai, Zhen; Wang, Chunge; Liu, Peiwen; Shen, Peng; Han, Yingying; Liu, Nawen Report Nov 15, 2016 5650
Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia. Sun, Jie; Hu, Juan; Huang, Yan; Ying, Shuang-Wei; Han, Xiao-Yan; Zheng, Yan-Long; Huang, He Report Oct 20, 2016 1331
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Stefano, J.T.; Pereira, I.V.A.; Torres, M.M.; Bida, P.M.; Coelho, A.M.M.; Xerfan, M.P.; Cogliati, B. Report May 1, 2015 4877
BLOMARCADORES EN LA DETECCION TEMPRANA DE CARDIOTOXICIDAD INDUCIDA POR QUIMIOTERAPIA; ESTADO ACTUAL. Jimenez Cotes, Evert Armando; Meyer Martinez, Wendy Sofia; Gallego Gonzalez, Daniel Jan 1, 2015 5822
Acute painful ophthalmoplegia in a patient with hepatocellular carcinoma. Tseng, Wei-Shih; Sung, Yueh-Feng Clinical report Jul 1, 2014 1587
Sorafenib-induced acute pancreatitis. Wang, Han-En; Chen, Chun-Ting; Huang, Hsin-Hung Report May 1, 2014 1045
What's new in renal cell cancer research? Highlights of GU-ASCO 2014. Kapoor, Anil Conference notes Mar 1, 2014 1701
Nuts against cancer. Moss, Ralph Report Feb 1, 2014 2113
Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report. Morita, Jun; Naoe, Michio; Ogawa, Yu; Nakasato, Takehiko; Sugahara, Motoko; Morita, Masashi; Fuji, K Clinical report May 1, 2013 2385
Study of RNA interference targeting NET-1 combination with sorafenib for hepatocellular carcinoma therapy in vitro and in vivo. He, Song; Wei, Ying-ze; Wang, Gui-lan; Xu, Yu-yin; Zhou, Jia-ming; Zhang, Yi-xin; Chen, Li Report Jan 1, 2013 4764
Sorafenib in advanced hepatocellular carcinoma: a nationwide retrospective study of efficacy and tolerability. Kostner, Anne Helene; Sorensen, Morten; Olesen, Rene Krojgaard; Gronbaek, Henning; Lassen, Ulrik; La Report Jan 1, 2013 3378
New thyroid cancer drug class making waves. Jancin, Bruce Dec 1, 2008 904
Watch side effects when using TKIs for thyroid cancer. Jancin, Bruce Dec 1, 2008 648
New drug for advanced liver cancer increases survival. McBride, Deborah Brief article Nov 1, 2007 209
Sorafenib extends survival in liver cancer patients. Wendling, Patrice Jul 1, 2007 490
Skin eruption tied to cancer agent. Tucker, Miriam E. Feb 15, 2007 978
New antiangiogenesis agents fight lung cancer. MacNeil, Jane Salodof Aug 1, 2006 947

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters